ATOSSA THERAPEUTICS, INC. Cost of Goods Sold (Deprecated 2018-01-31)
ATOSSA THERAPEUTICS, INC. (ATOS) reported Cost of Goods Sold (Deprecated 2018-01-31) of $132.41 thousand for the 12-month period ending 2015-12-31, per its 10-K/A filed 2017-03-21.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2017-03-21
- ATOSSA THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $1.64K.
- ATOSSA THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $0.00.
- ATOSSA THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $132.41K.
- ATOSSA THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- ATOSSA THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2013 was $239.75K.
- ATOSSA THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 41 month | Cost of Goods Sold (Deprecated 2018-01-31) 44 month | Cost of Goods Sold (Deprecated 2018-01-31) 47 month | Cost of Goods Sold (Deprecated 2018-01-31) 50 month | Cost of Goods Sold (Deprecated 2018-01-31) 53 month | Cost of Goods Sold (Deprecated 2018-01-31) 56 month | Cost of Goods Sold (Deprecated 2018-01-31) 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $132.41K 10-K/A · filed 2017-03-21 | ||||||||||
| 2015-03-31 | $1.64K 10-Q · filed 2015-05-13 | $1.64K derived: sum of 2 quarters · filed 2016-03-30 | $1.64K derived: sum of 3 quarters · filed 2016-03-30 | $1.64K derived: sum of 4 quarters · filed 2016-03-30 | |||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $0.00 derived: sum of 3 quarters · filed 2016-03-30 | $0.00 10-K · filed 2016-03-30 | |||||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 | $0.00 derived: sum of 2 quarters · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | $1.09K derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | $1.09K derived: sum of 3 quarters · filed 2015-05-13 | $1.09K derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-13 | $1.09K derived: sum of 2 quarters · filed 2015-05-13 | $1.09K derived: sum of 3 quarters · filed 2015-05-13 | $220.89K derived: sum of 4 quarters · filed 2015-05-13 | $244.92K 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | $1.09K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $1.09K derived: sum of 2 quarters · filed 2015-03-30 | $220.89K derived: sum of 3 quarters · filed 2015-03-30 | $239.75K 10-K · filed 2015-03-30 | $244.92K 10-K · filed 2014-03-27 | ||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-12 | $219.80K derived: sum of 2 quarters · filed 2014-11-12 | $238.67K 10-Q · filed 2014-11-12 | $238.67K derived: sum of 4 quarters · filed 2014-11-12 | $243.83K 10-Q · filed 2013-11-12 | ||||||
| 2013-06-30 | $219.80K 10-Q · filed 2014-08-12 | $238.67K 10-Q · filed 2014-08-12 | $238.67K derived: sum of 3 quarters · filed 2014-08-12 | $238.67K derived: sum of 4 quarters · filed 2014-08-12 | $243.83K 10-Q · filed 2013-08-14 | ||||||
| 2013-03-31 | $18.86K 10-Q · filed 2014-05-14 | $18.86K derived: sum of 2 quarters · filed 2014-05-14 | $18.86K derived: sum of 3 quarters · filed 2014-05-14 | $18.86K derived: sum of 4 quarters · filed 2014-05-14 | $24.03K 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 derived: sum of 2 quarters · filed 2014-03-27 | $0.00 derived: sum of 3 quarters · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 | $5.16K 10-K · filed 2013-03-28 | ||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | $5.16K derived: sum of 4 quarters · filed 2013-11-12 | $5.16K 10-Q/A · filed 2013-01-22 | ||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $5.16K derived: sum of 3 quarters · filed 2013-08-14 | $5.16K derived: sum of 4 quarters · filed 2013-08-14 | |||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | $5.16K derived: sum of 2 quarters · filed 2013-05-15 | $5.16K derived: sum of 3 quarters · filed 2013-05-15 | ||||||||
| 2011-12-31 | $5.16K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | $5.16K derived: sum of 2 quarters · filed 2013-03-28 | $5.16K 10-K · filed 2013-03-28 | ||||||||
| 2011-09-30 | $0.00 10-Q/A · filed 2013-01-22 | $0.00 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |